— Dennis Fournogerakis improves life sciences commercial operations with a focus on orphan drugs and specialty therapies —
EVANSTON, Ill. — July 16, 2019 — Life sciences consulting firm Beghou Consulting recently promoted advanced analytics and oncology expert Dennis Fournogerakis to associate partner. Fournogerakis works closely with life sciences companies to optimize their commercial operations in areas ranging from forecasting to incentive compensation to sales force design.
“Dennis has served as an invaluable adviser to our clients since joining our firm more than six years ago,” said Beth Beghou, founder and managing director of Beghou Consulting. “He guides life sciences companies through complex commercial obstacles and leverages advanced analytics to gain actionable insights. Besides his impressive client work, Dennis is a standout leader who goes the extra mile to mentor his colleagues and help them become better consultants.”
Fournogerakis builds and deploys machine learning models that allow life sciences companies to analyze large amounts of data and generate predictions and strategic recommendations for the sales force. He is a leader in advising pharmaceutical companies on commercial strategies for orphan drugs and CAR T therapies, in particular.
“Today’s emerging pharma companies have a unique opportunity to take advantage of plentiful new data sources to optimize sales and marketing efforts,” Fournogerakis said. “Proper data analysis and modeling are especially crucial when it comes to launching innovative therapies and addressing their many commercial challenges. I look forward to continuing to counsel life sciences companies on how to best tackle their pressing issues.”
Fournogerakis earned a doctorate in chemistry from Stanford University and a bachelor’s degree in chemistry from the University of Wisconsin-Madison. He works in the firm’s Evanston headquarters.